Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Greenhalf

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
British Journal of Cancer|March 3, 2016
Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinomaGary Middleton, William Greenhalf, Eithne Costello, et al.
The Journal of Gene Medicine|May 11, 2004
5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cellsChristopher M Halloran, Paula Ghaneh, Susannah Shore, et al.
Plos Medicine|April 26, 2007
Palladin mutation causes familial pancreatic cancer: absence in European familiesEmily Slater, Vera Amrillaeva, Volker Fendrich, et al.
Current Issues in Molecular Biology|March 28, 2023
Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle RegulationRobert Ferguson, Karen Aughton, Anthony Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 27, 2015
Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual MechanismsMichele Cioffi, Sara Trabulo, Manuel Hidalgo, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|June 25, 2025
Prevalence of New-Onset Diabetes in Patients Undergoing Pancreatic Surgery and the Association of Glucose Dysregulation With Complications in Pancreatic CancerMartyn Stott, Irena Stefanova, Lucy Oldfield, et al.
Human Mutation|September 1, 2005
Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriersJonathan A Cohn, John P Neoptolemos, Jinong Feng, et al.
Journal of Proteome Research|December 6, 2008
Confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancerLi Yan, Sarah Tonack, Richard Smith, et al.
JAMA Network Open|October 17, 2025
Cost-Effectiveness of Biomarker-Associated Early Pancreatic Cancer Detection in New-Onset DiabetesIrena Stefanova, Nathan Thompson, Lucy Oldfield, et al.
Scientific Reports|February 6, 2020
A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosisStephen J McWilliam, Anna Rosala-Hallas, Ashley P Jones, et al.
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
British Journal of Cancer|March 3, 2016
Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinomaGary Middleton, William Greenhalf, Eithne Costello, et al.
The Journal of Gene Medicine|May 11, 2004
5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cellsChristopher M Halloran, Paula Ghaneh, Susannah Shore, et al.
Plos Medicine|April 26, 2007
Palladin mutation causes familial pancreatic cancer: absence in European familiesEmily Slater, Vera Amrillaeva, Volker Fendrich, et al.
Current Issues in Molecular Biology|March 28, 2023
Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle RegulationRobert Ferguson, Karen Aughton, Anthony Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 27, 2015
Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual MechanismsMichele Cioffi, Sara Trabulo, Manuel Hidalgo, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|June 25, 2025
Prevalence of New-Onset Diabetes in Patients Undergoing Pancreatic Surgery and the Association of Glucose Dysregulation With Complications in Pancreatic CancerMartyn Stott, Irena Stefanova, Lucy Oldfield, et al.
Human Mutation|September 1, 2005
Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriersJonathan A Cohn, John P Neoptolemos, Jinong Feng, et al.
Journal of Proteome Research|December 6, 2008
Confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancerLi Yan, Sarah Tonack, Richard Smith, et al.
JAMA Network Open|October 17, 2025
Cost-Effectiveness of Biomarker-Associated Early Pancreatic Cancer Detection in New-Onset DiabetesIrena Stefanova, Nathan Thompson, Lucy Oldfield, et al.
Scientific Reports|February 6, 2020
A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosisStephen J McWilliam, Anna Rosala-Hallas, Ashley P Jones, et al.
Pageof 13